Welcome to the Hope Bio Blog

Thoughts in Honor of Atomic Veterans Day | Written by Jan Shultis Atomic Veterans Day, first designated by President Ronald Reagan in 1983, recognizes and honors the select group of military veterans who served in or around nuclear operations and nuclear campaigns. “Atomic veterans” are American service members who participated in nuclear tests between 1945 and 1962, served with United States military forces in or around Hiroshima and Nagasaki through mid-1946, or were held a

Hope Bio’s CTTACC 2023 Recap What do you get when you send two scientists and two executives to the desert? While you search for a punchline, we’ll supply our experientially discovered answer - you get great and growing industry relationships, breaking news in cell therapy and traumatic brain injury, and a whole lot o’ pictures of a cell culture flask in exotic (by cell culture flask standards) locations. CTTACC 2023 main session A huge “thank you” to Scottsdale, Arizona for

A four-year, nearly $5 million clinical trial grant awarded to UTHealth Houston by the Department of Defense’s Office of Congressionally Directed Medical Research Programs (CDMRP) will evaluate if intravenously infused Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) reduce chronic neuroinflammatory response to severe traumatic brain injury (TBI). UTHealth Houston and Hope Bio celebrating completion of treatments in the Phase I trial for Trauma